Searched for
GRANULES INDIA PHARMACEUTICALS
Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...- Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
- Granules India shares in focus on acquiring Swiss firm for Rs 192 crGranules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market presence. The ...
- Indian pharma firm Granules opens packaging facility in US' VirginiaGranules, which was one of the first Indian pharmaceutical companies that received FDA authorization to export to the United States, has in...
- Granules gets USFDA's nod for Amphetamine capsulesAmphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. T...
- Buy Granules India, target price Rs 338: ICICI DirectGranules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8005.63 Crore) operating in Pharmaceuti...
- Buy Granules India, target price Rs 345: ICICI DirectGranules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 7309.97 Crore) operating in Pharmaceuti...
- USFDA issues two observations after inspection of Granules India's Chantilly facility in US"We will be responding to the two observations within the stipulated time period," Granules Pharmaceuticals Executive Director Priyanka Chi...
- Granules arm gets American health regulator's nod for Potassium Chloride Oral SolutionIn a BSE filing, Granules said the US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed b...
- Granules India surges 10% as three PE firms look to pick controlling stakeA media report said that Blackstone, KKR and Bain Capital have submitted non-binding bids for the proposed transaction and investment bank ...
- Granules India gets USFDA nod for overactive bladder treatment capsule"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wh...
- Buy Granules India, price target Rs 140: Shrikant ChouhanThe analyst suggested a stop loss at Rs 129.
- Granules' US unit gets two USFDA observationsAs per the USFDA, a Form 483, is issued to a firm's management at the conclusion of an inspection when investigator has observed any condit...
- Granules India Q1 net profit rises by 37% to Rs 39 croreOperating margin improved by 96 basis points to 20.8 per cent from 19.9 per cent and net profit margin by 249 basis points to 11.3 per cent...
- Granules to acquire 12.5 per cent stake in USpharmaUSpharma is a development-stage pharmaceutical company specialising in research, development and manufacture of high entry-barrier generic ...
- Granules India's paracetamol facility passes USFDA inspectionGranules India has facilities for APIs, pharmaceutical formulation intermediates and finished dosages, serving customers in over 60 countri...
- Granules buys Auctus Pharma in Rs 100 crore dealHyderabad-based pharmaceutical firm Granules India has agreed to buy Auctus Pharma for about Rs 100 crore in an all-cash deal.
- Granules in alliance with US pharma coGranules and US' Heritage in strategic alliance for generic pharma products in the US.
- Granules India to raise 20 mn dollarsPharmaceutical formulation intermediates manufacturer, Granules India on Wednesday said it will consider raising up to 20 million dollar th...
- Granules looks to buy controlling stake in Chinese coHyderabad-based pharma firm Granules India is close to finalising a Rs 180-200-crore deal with a Chinese pharmaceutical company.
Load More
